Journal of Geriatric Cardiology 2023, 20(6): 399-430 https://doi.org/10.26599/1671-5411.2023.06.001

Special Article |

Open Access | Issue | Published: 15 June 2023

Report on cardiovascular health and diseases in China 2021: an updated summary

The Writing Committee of the Report on Cardiovascular Health and Diseases in China, Sheng-Shou HU(

)

Cite this article:

The Writing Committee of the Report on Cardiovascular Health and Diseases in China, HU S-S. Report on cardiovascular health and diseases in China 2021: an updated summary. Journal of Geriatric Cardiology, 2023, 20(6): 399-430. https://doi.org/10.26599/1671-5411.2023.06.001

Download citation

EndNote(RIS)

BibTeX

2130

Views

181

Downloads

Citations

Crossref

WoS

Scopus

CSCD

Abstract Full text About this article

Abstract

In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all deaths in rural and urban areas, respectively. Two out of every five deaths were attributed to CVD. It is estimated that approximately 330 million individuals in China are affected by CVD. Among them, there are 13 million cases of stroke, 11.4 million cases of coronary heart disease, 5 million cases of pulmonary heart disease, 8.9 million cases of heart failure, 4.9 million cases of atrial fibrillation, 2.5 million cases of rheumatic heart disease, 2 million cases of congenital heart disease, 45.3 million cases of lower extremity artery disease, and 245 million cases of hypertension. With the dual challenges of population aging and a steady increase in the prevalence of metabolic risk factors, the burden of CVD in China is expected to continue rising. Consequently, new demands arise for CVD prevention, treatment, and the allocation of medical resources. Emphasizing primary prevention to reduce disease prevalence, increasing the allocation of medical resources for CVD emergency and critical care, and providing rehabilitation services and secondary prevention to reduce the risk of recurrence, rehospitalization, and disability among CVD survivors are of paramount importance. Hypertension, dyslipidemia, and diabetes affect millions of individuals in China. Since blood pressure, blood lipids, and blood sugar levels often rise insidiously, vascular disease and serious events such as myocardial infarction and stroke occur by the time they are detected in this population. Therefore, it is crucial to implement strategies and measures to prevent risk factors such as hypertension, dyslipidemia, diabetes, obesity, and smoking. Furthermore, greater efforts should be directed towards assessing cardiovascular health status and conducting research on early pathological changes to enhance prevention, treatment, and understanding of CVD.

Full text

Abstract

Full text

Outline

About this article

Report on cardiovascular health and diseases in China 2021: an updated summary

The Writing Committee of the Report on Cardiovascular Health and Diseases in China, Sheng-Shou HU(

)

Abstract

References(118)

[1]

National Health Commission of the People’s Republic of China. 2020 Report on Health Hazards of Smoking in China [EB/OL]. (2021-5-31)[2022-04-21]. http://www.gov.cn/xinwen/2021-05/30/content_5613994.htm (accessed on June 6, 2022).

[2]

Chinese Center for Disease Control and Prevention. 2018 China adults tobacco survery [M]. Beijing: People’s Medical Publishing House, 2020.

[3]

Pang YJ, Yu CQ, Guo Y, et al. [Associations of lifestyles with major chronic diseases in Chinese adults: evidence from the China Kadoorie Biobank]. Zhonghua Liu Xing Bing Xue Za Zhi 2021; 42: 369−375. [In Chinese].

Google Scholar

[4]

Yu DM, Zhao LY, Ju LH, et al. [Status of energy and primary nutrients intake among Chinese population in 2015–2017]. Food Nutr China 2021; 27: 5−10. [In Chinese].

Google Scholar

[5]

Piao W, Yu DM, Ju LH, et al. [Intakes of energy and macronutrients in 6-11 years old age group in 2016-2017 in China]. Wei Sheng Yan Jiu 2021; 50: 389−394. [In Chinese].

Google Scholar

[6]

Ju L, Zhao L, Fang H, et al. [Status of dietary micronutrient intakes among the children of 12-17 years old in China from 2016 to 2017]. Wei Sheng Yan Jiu 2022; 51: 544−549. [In Chinese].

Google Scholar

[7]

Zhang J, Wang Z, Du W, et al. Twenty-five-year trends in dietary patterns among Chinese Adults from 1991 to 2015. Nutrients 2021; 13: 1327.

DOI Google Scholar

[8]

Liu SN, Zhang TW, Pan F, et al. [Analysis on sugar intake from carbonated beverages aged 3 years and above of China]. Chinese Journal of Food Hygiene 2020; 32: 556−560. [In Chinese].

Google Scholar

[9]

Bi XY, Li L, Yang TT, et al. [Snack consumption and the influencing factors of students participation in the Nutrition Improvement Program for Rural Compulsory Education in 2019]. Chin J Sch Health 2021; 42: 329−333. [In Chinese].

Google Scholar

[10]

Ju L, Yu D, Guo Q, et al. [Eating out behavior and its impact on obesity among Chinese residents aged 18-59 in 2015]. Wei Sheng Yan Jiu 2021; 50: 395−400. [In Chinese].

Google Scholar

[11]

Yao YC, Gong WY, Song C, et al. Out-of-home eating behavior analysis of Chinese adult residents, 2010-2012. Acta Nutrimenta Sinica 2019; 41: 10−14.

Google Scholar

[12]

Piao W, Zhao LY, Fang HY, et al. [Status of drinking behaviors in adults aged 18 years old and over in China]. Food Nutr China 2021; 27: 15−19. [In Chinese].

Google Scholar

[13]

Liu M, Wang CR, Liang JJ, et al. [Change trend in disease burden of stroke and its risk factors in China, 1990-2017]. Chin J Public Health 2021; 37: 1501−1507. [In Chinese].

Google Scholar

[14]

Han Y, Hu Y, Yu C, et al. Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study. Eur Heart J 2021; 42: 3374−3384.

DOI Google Scholar

[15]

Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med 2021; 385: 1067−1077.

DOI Google Scholar

[16]

Strain T, Brage S, Sharp SJ, et al. Use of the prevented fraction for the population to determine deaths averted by existing prevalence of physical activity: a descriptive study. Lancet Glob Health 2020; 8: e920−e930.

DOI Google Scholar

[17]

Cao J, Eshak ES, Liu K, et al. An age-period-cohort analysis of stroke mortality attributable to low physical activity in China and Japan: data from the GBD study 1990-2016. Sci Rep 2020; 10: 6525.

DOI Google Scholar

[18]

Liu Q, Liu FC, Huang KY, et al. Beneficial effects of moderate to vigorous physical activity on cardiovascular disease among Chinese adults. J Geriatr Cardiol 2020; 17: 85−95.

Google Scholar

[19]

Bennett DA, Du H, Clarke R, et al. Association of physical activity with risk of major cardiovascular diseases in Chinese men and women. JAMA Cardiol 2017; 2: 1349−1358.

DOI Google Scholar

[20]

Liu Y, Wen W, Gao YT, et al. Level of moderate-intensity leisure-time physical activity and reduced mortality in middle-aged and elderly Chinese. J Epidemiol Community Health 2018; 72: 13−20.

DOI Google Scholar

[21]

Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol 2021; 9: 373−392.

DOI Google Scholar

[22]

Mu L, Liu J, Zhou G, et al. Obesity prevalence and risks among Chinese adults: findings from the China PEACE million persons project, 2014–2018. Circ Cardiovasc Qual Outcomes 2021; 14: e007292.

DOI Google Scholar

[23]

Wang Y, Zhao L, Gao L, et al. Health policy and public health implications of obesity in China. Lancet Diabetes Endocrinol 2021; 9: 446−461.

DOI Google Scholar

[24]

Chen Z, Jiang S, Wang Y, et al. Pharmacoeconomics of obesity in China: a scoping review. Expert Rev Pharmacoecon Outcomes Res 2021; 21: 173−181.

DOI Google Scholar

[25]

Zhao D, Wu Z, Zhang H, et al. Somatic symptoms vary in major depressive disorder in China. Compr Psychiatry 2018; 87: 32−37.

DOI Google Scholar

[26]

Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey 2012-2015. Circulation 2018; 137: 2344−2356.

DOI Google Scholar

[27]

Zhang M, Wu J, Zhang X, et al. [Prevalence and control of hypertension in adults in China, 2018]. Zhonghua Liu Xing Bing Xue Za Zhi 2021; 42: 1780−1789. [In Chinese].

Google Scholar

[28]

Luo Y, Xia F, Yu X, et al. Long-term trends and regional variations of hypertension incidence in China: a prospective cohort study from the China Health and Nutrition Survey, 1991–2015. BMJ Open 2021; 11: e042053.

DOI Google Scholar

[29]

Zhang W, Zhang S, Deng Y, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med 2021; 385: 1268−1279.

DOI Google Scholar

[30]

Xie X, He T, Kang J, et al. Cost-effectiveness analysis of intensive hypertension control in China. Prev Med 2018; 111: 110−114.

DOI Google Scholar

[31]

Wang Z, Hao G, Wang X, et al. Clinical outcomes and economic impact of the 2017 ACC/AHA guidelines on hypertension in China. J Clin Hypertens (Greenwich) 2019; 21: 1212−1220.

DOI Google Scholar

[32]

Zhang SY, Tao LY, Yang YY, et al. Evaluation of blood pressure lowering effect by generic and brand-name antihypertensive drugs treatment: a multicenter prospective study in China. Chin Med J (Engl) 2021; 134: 292−301.

DOI Google Scholar

[33]

Dong J, Dong H, Yan Y, et al. Prevalence of hypertension and hypertension phenotypes after three visits in Chinese urban children. J Hypertens 2022; 40: 1270−1277.

DOI Google Scholar

[34]

Xu H, Li Y, Shang X, et al. Effect of comprehensive interventions including nutrition education and physical activity on high blood pressure among children: evidence from school-based cluster randomized control trial in China. Int J Environ Res Public Health 2020; 17: 8944.

DOI Google Scholar

[35]

Song PK, Man QQ, Li H, et al. Trends in lipids level and dyslipidemia among Chinese adults, 2002–2015. Biomed Environ Sci 2019; 32: 559−570.

Google Scholar

[36]

NCD Risk Factor Collaboration (NCD-RisC). Repositioning of the global epicentre of non-optimal cholesterol. Nature 2020; 582: 73−77.

DOI Google Scholar

[37]

Pan L, Yang Z, Wu Y, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis 2016; 248: 2−9.

DOI Google Scholar

[38]

Dai J, Min JQ, Yang YJ, et al. [A study on the epidemic characteristics of dyslipidemia in adults of nine provinces of China]. Zhonghua Xin Xue Guan Bing Za Zhi 2018; 46: 114−118. [In Chinese].

Google Scholar

[39]

Li SN, Zhang LF, Wang X, et al. [Status of dyslipidemia among adults aged 35 years and above in China]. Chin Circ J 2019; 34: 681−687. [In Chinese].

Google Scholar

[40]

Opoku S, Gan Y, Fu W, et al. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China national stroke screening and prevention project (CNSSPP). BMC Public Health 2019; 19: 1500.

DOI Google Scholar

[41]

Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163, 641 adults. Int J Cardiol 2018; 260: 196−203.

DOI Google Scholar

[42]

Wang ZH, Zou ZY, Yang YD, et al. [The epidemiological characteristics and related factors of dyslipidemia among children and adolescents aged 6-17 years from 7 provinces in China, 2012]. Zhonghua Yu Fang Yi Xue Za Zhi 2018; 52: 798−801. [In Chinese].

Google Scholar

[43]

Zhao W, Ye P, Hu DY, et al. [Re-analysis of DYSIS-China cross-sectional survey according to “Chinese guidelines for the prevention and treatment of dyslipidemia in adults (2016 revision)”]. Chin J Cardiovasc Med 2020; 25: 55−61. [In Chinese].

Google Scholar

[44]

Xing Y, Liu J, Hao Y, et al. Prehospital statin use and low- density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: findings from the improving care for cardiovascular disease in China (CCC) project. Am Heart J 2019; 212: 120−128.

DOI Google Scholar

[45]

Xing YY, Liu J, Liu J, et al. [Statin use and low-density lipoprotein cholesterol levels in patients aged 75 years and older with acute coronary syndrome in China]. Zhonghua Xin Xue Guan Bing Za Zhi 2019; 47: 351−359. [In Chinese].

Google Scholar

[46]

Xu XH, Yang J, Wang LJ, et al. [Burden of disease attributed to high level serum low-density lipoprotein cholesterol in China in 2017]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41: 839−844. [In Chinese].

Google Scholar

[47]

Song YJ, Du X, Zheng MY, et al. [A prospective cohort study of the effect of cumulative exposure to low density lipoprotein cholesterol on new-onset acute myocardial infarction]. Chin Circ J 2020; 35: 246−253. [In Chinese].

Google Scholar

[48]

Sun L, Clarke R, Bennett D, et al. Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults. Nat Med 2019; 25: 569−574.

DOI Google Scholar

[49]

Wang M, Liu J, Bellows BK, et al. Impact of China's low centralized medicine procurement prices on the cost-effectiveness of statins for the primary prevention of atherosclerotic cardiovascular disease. Glob Heart 2020; 15: 43.

DOI Google Scholar

[50]

Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross-sectional study. BMJ 2020, 369: m997.

DOI

[51]

Wang M, Gong WW, Pan J, et al. Incidence and time trends of type 2 diabetes mellitus among adults in Zhejiang province, China, 2007-2017. J Diabetes Res 2020; 2597953.

DOI

[52]

Gong Q, Zhang P, Wang J, et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study. Lancet Diabetes Endocrinol 2019; 7: 452−461.

DOI Google Scholar

[53]

Ma J, Wan X, Wu B. The cost-effectiveness of lifestyle interventions for preventing diabetes in a health resource-limited setting. J Diabetes Res 2020; 7410797.

DOI

[54]

Jin H, Zhou J, Wu C, Prevalence and health correlates of reduced kidney function among community-dwelling Chinese older adults: the China Health and Retirement Longitudinal Study. BMJ Open 2020; 10: e042396.

DOI

[55]

Zhang L, Zhao MH, Zuo L, et al. China Kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int Suppl 2020; 10: e97−e185.

DOI Google Scholar

[56]

Zhang M, Deng Q, Wang L, et al. Corrigendum to “Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163, 641 adults” [Int J Cardiol 2018; 260: 196-203]. Int J Cardiol 2018; 267: 218.

DOI Google Scholar

[57]

Liang F, Xiao Q, Huang K, et al. The 17-y spatiotemporal trend of PM2. 5 and its mortality burden in China. Proc Natl Acad Sci U S A 2020; 117: 25601−25608.

DOI Google Scholar

[58]

Liu C, Yin P, Chen R, et al. Ambient carbon monoxide and cardiovascular mortality: a nationwide time-series analysis in 272 cities in China. Lancet Planet Health 2018; 2: e12−e18.

DOI Google Scholar

[59]

Chen R, Yin P, Meng X, et al. Fine particulate air pollution and daily mortality. a nationwide analysis in 272 Chinese cities. Am J Respir Crit Care Med 2017; 196: 73−81.

DOI Google Scholar

[60]

Chen R, Yin P, Meng X, et al. Associations between ambient nitrogen dioxide and daily cause-specific mortality: evidence from 272 Chinese cities. Epidemiology 2018, 29: 482-489.

DOI

[61]

Chen R, Yin P, Meng X, et al. Associations between coarse particulate matter air pollution and cause-specific mortality: a nationwide analysis in 272 Chinese cities. Environ Health Perspect 2019; 127: 17008.

DOI Google Scholar

[62]

Yu K, Lv J, Qiu G, et al. Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study. Lancet Glob Health 2020; 8: e430−e439.

DOI Google Scholar

[63]

Hou L, Chen B, Ji Y, et al. China CDC in action–hypertension prevention and control. China CDC Wkly 2020, 2: 783-786.

DOI

[64]

National Health Commission of the People’s Republic of China. China health statistics yearbook 2020. Beijing: Peking Union Medical College Press, 2020.

[65]

Zhong Q, Gao Y, Zheng X, et al. Geographic variation in process and outcomes of care for patients with acute myocardial infarction in China from 2001 to 2015. JAMA Netw Open 2020; 3: e2021182.

DOI Google Scholar

[66]

Xu H, Yang Y, Wang C, et al. Association of hospital-level differences in care with outcomes among patients with acute ST-segment elevation myocardial infarction in China. JAMA Netw Open 2020; 3: e2021677.

DOI Google Scholar

[67]

Atkins ER, Du X, Wu Y, et al. Use of cardiovascular prevention treatments after acute coronary syndrome in China and associated factors. Int J Cardiol 2017; 241: 444−449.

DOI Google Scholar

[68]

Li J, Dharmarajan K, Bai X, et al. Thirty-day hospital readmission after acute myocardial infarction in China. Circ Cardiovasc Qual Outcomes 2019; 12: e005628.

DOI Google Scholar

[69]

Song J, Murugiah K, Hu S, et al. Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China. Heart 2020; 107: 313−318.

DOI Google Scholar

[70]

Zhao YY, Yang JG, Xu HB, et al. [Association between the composite measures of hospital performance and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction in China]. Chin Circ J 2019; 34: 437−443. [In Chinese].

Google Scholar

[71]

National Center for Cardiovascular Quality Improvement. [2021 medical quality report of cardiovascular diseases in China: an executive summary]. Chin Circ J 2021; 36: 1041−1064.

Google Scholar

[72]

Hu Z, Chen S, Du J, et al. An in-hospital mortality risk model for patients undergoing coronary artery bypass grafting in China. Ann Thorac Surg 2020; 109: 1234−1242.

DOI Google Scholar

[73]

Lin S, Li Z, Fu B, et al. Feasibility of using deep learning to detect coronary artery disease based on facial photo. Eur Heart J 2020; 41: 4400−4411.

DOI Google Scholar

[74]

GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021; 20: 795−820.

DOI Google Scholar

[75]

Xia F, Yu X, Li Y, et al. Geographic variations of stroke incidence in Chinese communities: an 18-year prospective cohort study from 1997 to 2015. J Stroke 2020; 22: 345−356.

DOI Google Scholar

[76]

Jiang B, Sun H, Ru X, et al. Prevalence, incidence, prognosis, early stroke risk, and stroke-related prognostic factors of definite or probable transient ischemic attacks in China, 2013. Front Neurol 2017; 8: 309.

DOI Google Scholar

[77]

Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480687 adults. Circulation 2017; 135: 759−771.

DOI Google Scholar

[78]

Gu M, Hu Y, Hua W, et al. Visualization of tricuspid valve annulus for implantation of His bundle pacing in patients with symptomatic bradycardia. J Cardiovasc Electrophysiol 2019; 30: 2164−2169.

DOI Google Scholar

[79]

Wang Z, Chen Z, Wang X, et al. The disease burden of atrial fibrillation in China from a national cross-sectional survey. Am J Cardiol 2018; 122: 793−798.

DOI Google Scholar

[80]

Guo J, Guan T, Fan S, et al. Underuse of oral anticoagulants in patients with ischemic stroke and atrial fibrillation in China. Am J Cardiol 2018; 122: 2055−2061.

DOI Google Scholar

[81]

Liu Y, Zhan X, Xue Y, et al. Incidence and outcomes of cerebrovascular events complicating catheter ablation for atrial fibrillation. Europace 2016; 18: 1357−1365.

DOI Google Scholar

[82]

Ge HY, Li XM, Jiang H, et al. Clinical characteristics and treatment of congenital long QT syndrome in 58 children. Chin J Pediatr 2019; 57: 272−276.

Google Scholar

[83]

Jia P L, Wang YB, Fu H, et al. Postmortem analysis of 4 mutation hotspots of KCNQ1, KCNH2, and SCN5A genes in sudden unexplained death in southwest of China. Am J Forensic Med Pathol 2018; 39: 218−222.

DOI Google Scholar

[84]

Yang Y, Wang Z, Chen Z, et al. Current status and etiology of valvular heart disease in China: a population-based survey. BMC Cardiovasc Disord 2021; 21: 339.

DOI Google Scholar

[85]

Wang Y, Wu B, Li J, et al. Distribution patterns of valvular and vascular complications in bicuspid aortic valve. Int Heart J 2020; 61: 273−280.

DOI Google Scholar

[86]

Zhao L, Chen L, Yang T, et al. Birth prevalence of congenital heart disease in China, 1980-2019: a systematic review and meta-analysis of 617 studies. Eur J Epidemiol 2020; 35: 631−642.

DOI Google Scholar

[87]

Zhao QM, Liu F, Wu L, et al. Prevalence of congenital heart disease at live birth in China. J Pediatr 2019; 204: 53−58.

DOI Google Scholar

[88]

Chinese Society of Extracorporeal Circulation. [White book of Chinese cardiovascular surgery and extracorporeal circulation in 2020]. Chin J ECC 2021; 19: 257−260. [In Chinese].

Google Scholar

[89]

Cooperation Group of Precision Diagnosis and Treatment of Cardiomyopathy in Children, the Subspecialty Group of Cardiology, the Society of Pediatrics, Chinese Medical Association. [Investigation and analysis of cardiomyopathy in children from 33 hospitals in China: a multicenter study of 4981 cases from 2006 to 2018]. Chin J Appl Clin Pediatr 2021; 36: 983−989. [In Chinese].

Google Scholar

[90]

Wu G, Liu L, Zhou Z, et al. East Asian-specific common variant in TNNI3 predisposes to hypertrophic cardiomyopathy. Circulation 2020; 142: 2086−2089.

DOI Google Scholar

[91]

Christensen AH, Platonov PG, Jensen HK, et al. Genotype-phenotype correlation in arrhythmogenic right ventricular cardiomyopathy-risk of arrhythmias and heart failure. J Med Genet 2022; 59: 858−864.

DOI Google Scholar

[92]

Chen L, Rao M, Chen X, et al. A founder homozygous DSG2 variant in East Asia results in ARVC with full penetrance and heart failure phenotype. Int J Cardiol 2019, 274: 263-270.

DOI

[93]

Rao M, Guo G, Li M, et al. The homozygous variant c. 245G > A/p. G82D in PNPLA2 is associated with arrhythmogenic cardiomyopathy phenotypic manifestations. Clin Genet 2019; 96: 532−540.

DOI Google Scholar

[94]

Sun H, Hao X, Wang X, et al. Genetics and clinical features of noncompaction cardiomyopathy in the fetal population. Front Cardiovasc Med 2020; 7: 617561.

DOI Google Scholar

[95]

Hao G, Wang X, Chen Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail 2019; 21: 1329−1337.

DOI Google Scholar

[96]

Zhang Y, Zhang J, Butler J, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China Heart Failure (China-HF) Registry. J Card Fail 2017; 23: 868−875.

DOI Google Scholar

[97]

Working Group on Heart Failure, National Center for Cardiovascular Quality Improvement (NCCQI). [2020 Clinical Performance and quality measures for heart failure in China]. Chin Circ J 2021; 36: 221−238. [In Chinese].

Google Scholar

[98]

Li Y, Sun XL, Qiu H, et al. Long-term outcomes and independent predictors of mortality in patients presenting to emergency departments with acute heart failure in Beijing: a multicenter cohort study with a 5-year follow-up. Chin Med J (Engl) 2021; 134: 1803−1811.

DOI Google Scholar

[99]

Li M, Wang Q, Zhao J, et al. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Lupus 2014; 23: 1085−1091.

DOI Google Scholar

[100]

Zhang R, Dai LZ, Xie WP, et al. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era. Chest 2011; 140: 301−309.

DOI Google Scholar

[101]

Zhang Z, Lei J, Shao X, et al. Trends in hospitalization and in- hospital mortality from VTE, 2007 to 2016, in China. Chest 2019; 155: 342−353.

DOI Google Scholar

[102]

Zhai Z, Wang D, Lei J, et al. Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: an analysis from the China pulmonary thromboembolism registry study (CURES). Eur Respir J 2021; 58: 2002963.

DOI Google Scholar

[103]

Zhai Z, Kan Q, Li W, et al. VTE risk profiles and prophylaxis in medical and surgical inpatients: the identification of Chinese hospitalized patients’ risk profile for venous thromboembolism (DissolVE-2)-A cross-sectional study. Chest 2019; 155: 114−122.

DOI Google Scholar

[104]

Xia L, Li JH, Zhao K, et al. Incidence and in-hospital mortality of acute aortic dissection in China: analysis of China Health Insurance Research (CHIRA) Data 2011. J Geriatr Cardiol 2015; 12: 502−506.

Google Scholar

[105]

Li K, Zhang K, Li T, et al. Primary results of abdominal aortic aneurysm screening in the at-risk residents in middle China. BMC Cardiovasc Disord 2018; 18: 60.

DOI Google Scholar

[106]

Jiang B, Li XT, Zhang DM, et al. [Preliminary results of ultrasound screening program for abdominal aortic aneurysm in Liaoning Province, Northeast China. ] Chin J Vasc Surg 2019; 4: 20−24. [In Chinese].

Google Scholar

[107]

Huang T, Liu S, Huang J, et al. Meta-analysis of the growth rates of abdominal aortic aneurysm in the Chinese population. BMC Cardiovasc Disord 2019; 19: 204.

DOI Google Scholar

[108]

Wang Z, Wang X, Hao G, et al. A national study of the prevalence and risk factors associated with peripheral arterial disease from China: the China hypertension survey, 2012–2015. Int J Cardiol 2019; 275: 165−170.

DOI Google Scholar

[109]

Hua Y, Jia L, Xing Y, et al. Distribution pattern of atherosclerotic stenosis in Chinese patients with stroke: a multicenter registry study. Aging Dis 2019; 10: 62−70.

DOI Google Scholar

[110]

Report on stroke prevention and treatment in China Writing Group. Brief report on stroke prevention and treatment in China, 2019. Chin J Cerebrovasc Dis 2020; 17: 272−281.

Google Scholar

[111]

Xiong HL, Peng M, Jiang XJ, et al. Time trends regarding the etiology of renal artery stenosis: 18 years' experience from the China Center for Cardiovascular Disease. J Clin Hypertens (Greenwich) 2018; 20: 1302−1309.

DOI Google Scholar

[112]

Che WQ, Jiang XJ, Dong H, et al. [Etiology and anatomic characteristics of subclavian artery stenosis: analysis of data from 1793 patients hospitalized in Fuwai Hospital between 1999 and 2017]. Chinese Circulation Journal 2018; 33: 1197−1202. [In Chinese].

Google Scholar

[113]

Liu D, Ma Z, Yang J, et al. Prevalence and prognosis significance of cardiovascular disease in cancer patients: a population-based study. Aging (Albany NY) 2019; 11: 7948−7960.

DOI Google Scholar

[114]

Zhang Z, Pack Q, Squires RW, et al. Availability and characteristics of cardiac rehabilitation programmes in China. Heart Asia 2016; 8: 9−12.

DOI Google Scholar

[115]

Li J, Li LSW. Development of rehabilitation in China. Phys Med Rehabil Clin N Am 2019; 30: 769−773.

DOI Google Scholar

[116]

Zhang N, Zhang YMF, Liu JY, et al. [National rehabilitation medicine professional medical service and quality safety report (2019)]. Chin J Phys Med Rehabil 2020; 42: 1146−1152. [In Chinese].

Google Scholar

[117]

Zhang YMF, Fan J, Zhou MW, et al. [2013-2018 Report on medical service and quality safety of inpatients in rehabilitation medicine department of national grade III hospitals: evidence based on the first page data of medical records in hospital quality monitoring system]. Chin J Phys Med Rehabil 2020; 35: 771−774. [In Chinese].

Google Scholar

[118]

National Center for Cardiovascular Diseases. Report on Cardiovascular Health and Diseases in China 2021: an Updated Summary Beijing: Science press, 2022.

About this article

Publication history

Acknowledgements

Rights and permissions

Publication history

Published: 15 June 2023

Issue date: June 2023

Copyright

Acknowledgements

ACKNOWLEDGEMENTS

The authors would like to express their gratitude to all the experts who contributed to the preparation of the Report on Cardiovascular Health and Diseases in China 2021, as listed in reference.^[118]